USA - New York Stock Exchange - NYSE:ABT - US0028241000 - Common Stock
Overall ABT gets a fundamental rating of 6 out of 10. We evaluated ABT against 184 industry peers in the Health Care Equipment & Supplies industry. While ABT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ABT is not valued too expensively and it also shows a decent growth rate. ABT also has an excellent dividend rating. These ratings could make ABT a good candidate for dividend investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.21 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.89 | ||
| Fwd PE | 18.76 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.05 | ||
| EV/EBITDA | 17.41 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.35% |
ChartMill assigns a fundamental rating of 6 / 10 to ABT.
ChartMill assigns a valuation rating of 6 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.
ABBOTT LABORATORIES (ABT) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 20.89 and the Price/Book (PB) ratio is 3.67.
The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.35% in the next year.